Gainers
Biofrontera Inc. (NASDAQ: BFRI) shares climbed 30.7% to $4.4095 after the company provided an update on patient recruitment for the Phase III study for the treatment of sBCC with Ameluz-PDT.
Kemper (NYSE:KMPR) reported its Q4 earnings results on Monday, January 31, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.